BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28358312)

  • 1. Chemical Synthesis and Characterization of an Equinatoxin II(1-85) Analogue.
    Karas JA; Sani MA; Separovic F
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28358312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of lipids on the structure of the eukaryotic cytolysin equinatoxin II: a synchrotron radiation circular dichroism spectroscopic study.
    Miles AJ; Drechsler A; Kristan K; Anderluh G; Norton RS; Wallace BA; Separovic F
    Biochim Biophys Acta; 2008 Oct; 1778(10):2091-6. PubMed ID: 18440301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipid on the conformation of the N-terminal region of equinatoxin II: a synchrotron radiation circular dichroism spectroscopic study.
    Drechsler A; Miles AJ; Norton RS; Wallace BA; Separovic F
    Eur Biophys J; 2009 Dec; 39(1):121-7. PubMed ID: 19343335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-state NMR and simulation studies of equinatoxin II N-terminus interaction with lipid bilayers.
    Lam YH; Hung A; Norton RS; Separovic F; Watts A
    Proteins; 2010 Mar; 78(4):858-72. PubMed ID: 19847922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutron reflection study of the interaction of the eukaryotic pore-forming actinoporin equinatoxin II with lipid membranes reveals intermediate states in pore formation.
    Wacklin HP; Bremec BB; Moulin M; Rojko N; Haertlein M; Forsyth T; Anderluh G; Norton RS
    Biochim Biophys Acta; 2016 Apr; 1858(4):640-52. PubMed ID: 26706098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and activity of the N-terminal region of the eukaryotic cytolysin equinatoxin II.
    Drechsler A; Potrich C; Sabo JK; Frisanco M; Guella G; Dalla Serra M; Anderluh G; Separovic F; Norton RS
    Biochemistry; 2006 Feb; 45(6):1818-28. PubMed ID: 16460028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the eukaryotic pore-forming cytolysin equinatoxin II with model membranes: 19F NMR studies.
    Anderluh G; Razpotnik A; Podlesek Z; Macek P; Separovic F; Norton RS
    J Mol Biol; 2005 Mar; 347(1):27-39. PubMed ID: 15733915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function studies of tryptophan mutants of equinatoxin II, a sea anemone pore-forming protein.
    Malovrh P; Barlic A; Podlesek Z; MaCek P; Menestrina G; Anderluh G
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):223-32. PubMed ID: 10657261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the eukaryotic pore-forming cytolysin Equinatoxin II on lipid membranes and the role of sphingomyelin.
    Bonev BB; Lam YH; Anderluh G; Watts A; Norton RS; Separovic F
    Biophys J; 2003 Apr; 84(4):2382-92. PubMed ID: 12668447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the Lipid-Binding Site of Equinatoxin II by NMR and Molecular Dynamics Simulation.
    Weber DK; Yao S; Rojko N; Anderluh G; Lybrand TP; Downton MT; Wagner J; Separovic F
    Biophys J; 2015 Apr; 108(8):1987-96. PubMed ID: 25902438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-state NMR study of membrane interactions of the pore-forming cytolysin, equinatoxin II.
    Drechsler A; Anderluh G; Norton RS; Separovic F
    Biochim Biophys Acta; 2010 Feb; 1798(2):244-51. PubMed ID: 19857458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane damage by an α-helical pore-forming protein, Equinatoxin II, proceeds through a succession of ordered steps.
    Rojko N; Kristan KČ; Viero G; Žerovnik E; Maček P; Dalla Serra M; Anderluh G
    J Biol Chem; 2013 Aug; 288(33):23704-15. PubMed ID: 23803608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging the lipid-phase-dependent pore formation of equinatoxin II in droplet interface bilayers.
    Rojko N; Cronin B; Danial JS; Baker MA; Anderluh G; Wallace MI
    Biophys J; 2014 Apr; 106(8):1630-7. PubMed ID: 24739162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photobleaching reveals heterogeneous stoichiometry for equinatoxin II oligomers.
    Baker MA; Rojko N; Cronin B; Anderluh G; Wallace MI
    Chembiochem; 2014 Sep; 15(14):2139-45. PubMed ID: 25138674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the soluble form of equinatoxin II, a pore-forming toxin from the sea anemone Actinia equina.
    Athanasiadis A; Anderluh G; Macek P; Turk D
    Structure; 2001 Apr; 9(4):341-6. PubMed ID: 11525171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-step membrane binding by Equinatoxin II, a pore-forming toxin from the sea anemone, involves an exposed aromatic cluster and a flexible helix.
    Hong Q; Gutierrez-Aguirre I; Barlic A; Malovrh P; Kristan K; Podlesek Z; Macek P; Turk D; Gonzalez-Manas JM; Lakey JH; Anderluh G
    J Biol Chem; 2002 Nov; 277(44):41916-24. PubMed ID: 12198118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity of an α-pore-forming toxin depends on the assembly mechanism on the target membrane as revealed by single molecule imaging.
    Subburaj Y; Ros U; Hermann E; Tong R; García-Sáez AJ
    J Biol Chem; 2015 Feb; 290(8):4856-4865. PubMed ID: 25525270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure of the eukaryotic pore-forming cytolysin equinatoxin II: implications for pore formation.
    Hinds MG; Zhang W; Anderluh G; Hansen PE; Norton RS
    J Mol Biol; 2002 Feb; 315(5):1219-29. PubMed ID: 11827489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pore formation by equinatoxin, a eukaryotic pore-forming toxin, requires a flexible N-terminal region and a stable beta-sandwich.
    Kristan K; Podlesek Z; Hojnik V; Gutiérrez-Aguirre I; Guncar G; Turk D; González-Mañas JM; Lakey JH; Macek P; Anderluh G
    J Biol Chem; 2004 Nov; 279(45):46509-17. PubMed ID: 15322132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinants of sphingomyelin specificity of a eukaryotic pore-forming toxin.
    Bakrac B; Gutiérrez-Aguirre I; Podlesek Z; Sonnen AF; Gilbert RJ; Macek P; Lakey JH; Anderluh G
    J Biol Chem; 2008 Jul; 283(27):18665-77. PubMed ID: 18442982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.